Mediclinic sees higher FY revenues as strong performance continues
Private healthcare group Mediclinic said it expected expects full-year revenues to grow by around 6.5% as its strong first half performance continued.
FTSE 250
19,806.88
08:49 24/04/24
n/a
n/a
FTSE 350
4,440.50
08:50 24/04/24
n/a
n/a
FTSE All-Share
4,394.49
08:50 24/04/24
n/a
n/a
Health Care Equipment & Services
11,713.81
08:29 24/04/24
-0.20%
-23.76
Mediclinic International
501.00p
16:40 25/05/23
0.00%
0.00p
Mediclinic added that its earnings before interest, tax, depreciation and amortisation (EBITDA) margin remained unchanged.
As a result of higher staffing levels, together with an expected lower margin contribution from the Intercare business and the ramp-up of its new Stellenbosch facility, Mediclinic anticipated a full-year EBITDA margin of around 20%.
As of 0840 GMT, Mediclinic shares were up 1.04% to 388.90p.